Program Details

Supported by an educational grant from B|Braun.

Intended Audience
Nurses seeking knowledge in the areas of essentials of Nursing Care in Infusion Therapy, the Role of Nursing in Cancer Continuum Care, and Common Challenges/Complications in Intravenous Cannulation.

Learning Objectives
Upon completion of this activity, the participant should be able to:
1. Essentials of Nursing Care in Infusion Therapy
2. Role of Nursing in Cancer Continuum Care
3. Common Challenges/Complications in Intravenous Cannulation

Statement of Need
Create a program on “Safe Infusion Therapy in Nursing Practice” for Nurses to make them well equipped with the desired knowledge which is essential for their daily practice. Educate Nurses leading to enhancement in practice and thus, improved treatment outcomes.

Nurses
Dannemiller designates this educational activity for 2 CE contact hours.

Method of Participation
Participants should first read the objectives and other introductory CME/CE information and then proceed to the educational activity. If a pre- and post-test are required in order to receive credit for this activity, participants must complete the post-test with a passing score of 80% and then complete the evaluation. To receive credit for this activity, complete and submit the evaluation at the end of your activity. Credit is provided through December 31, 2024. No credit will be given after this date.

Faculty
Dr. Shwetal Sanghvi

Disclosures
In accordance with Joint Accreditation, Dannemiller requires that any person who is in a position to control the content of a CME/CE activity must disclose all financial relationships they have with ineligible companies.
The following faculty stated they have no financial relationships with ineligible companies:
• Dr. Shwetal Sanghvi

Dr. Shoma P. Shetty, Clinical Content Reviewer has stated she has no financial relationships with ineligible companies. Kim DuQue Urdialez, Dannemiller Project Manager, and Aditi Munghate, Insignia Planner, stated they have no financial relationships with ineligible companies.
To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current and evidence-based to protect
learners from commercial bias and marketing.

Off-label Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications,
contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller or B|Braun. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject.